Russian Journal of Infection and ImmunityRussian Journal of Infection and Immunity2220-76192313-7398SPb RAACI203210.15789/2220-7619-INI-2032Research ArticleIntrathecal nonspecific immunoglobulin synthesis in syphilitic infectionPonomarevaMarina V.<p>PhD (Biology), Senior Researcher, Department of Laboratory Medicine</p>marpo08@mail.ruLevchikNadezhda K.<p>PhD (Medicine), Associate Professor, Head of the Scientific and Сlinical Department of Syphilidology and STD</p>marpo08@mail.ruZilberbergNatalya V/<p>DSc (Medicine), Professor, Deputy Director</p>marpo08@mail.ruUrals Institute of Dermatovenereology and Immunopathology240420231323093181609202225022023Copyright © 2023, Ponomareva M.V., Levchik N.K., Zilberberg N.V.2023<p>Intrathecal Ig synthesis is one of the characteristic laboratory features of neurosyphilis (caused by <em>Treponema pallidum</em> subspecies pallidum able to affect the central nervous system (CNS), but a persisting pathogen-driven immune response is problem of scar effect. This long-term Ig production within the CNS compartment even after timely and proper treatment remains unexplored. We hypothesized that a long-term current chronic inflammation in the CNS caused by syphilitic infection can be a trigger of nonspecific humoral immune response and the scar effect may result from non-specific B cell activation within the CNS in the absence of antigens. The MRZ reaction is a laboratory tool for detection of intrathecal nonspecific humoral immune reaction, which is poorly investigated in syphilis patient. The MRZ reaction (MRZR) is used as a marker of intrathecal nonspecific humoral immune response and is composed of the three antibody indices (AI) against neurotropic viruses: measles, rubella and varicella zoster virus. A positive MRZR, defined as an elevated AIs ( 1.5) against at least one or more viral agents, confirms diagnosis of a chronic or autoimmune disease involving CNS recently declared as a highly specific marker of multiple sclerosis. Insufficient data on neuroinfections motivated us to examine a hypothesis that a long-term chronic inflammation within the CNS compartment caused by syphilitic infection may be a trigger of intrathecal nonspecific humoral immune response. We assessed prevalence of positive MRZR in 147 patients with later-stage syphilis seropositive for MRZ viruses. Study group included 43 patients with first-time diagnosed neurosyphilis, 16 patients with a follow-up visit after neurosyphilis treatment, 88 patients with excluded neurosyphilis. There were no significant differences between categories of patients examined, and presence of positive MRZR was not associated with any demographic, clinical and laboratory characteristics. To sum up, our study (n = 147) showed that 27 patients (18%, 95% CI: 1225% ) were positive for intrathecal Ig production against one, two or three of the M, R, Z viruses, and bi- and tri-specific MRZR was present in 7 of 147 patients (5%, 95% CI: 210%). The data obtained evidence that frequency of the MRZR for syphilitic infection matches that of found in general population and a long-term current syphilitic infection affecting CNS seems to not be a trigger of a nonspecific intrathecal immune response. Among our patients, we also selected 43 patients with previously treated syphilitic infection without any neurological symptoms and excluded neurosyphilis diagnosis, so these patients can be considered as an apparently healthy group.</p>intrathecal Ig synthesisMRZ reactionneurosyphilissyphilisantibody indicescerebrospinal fluidneurotropic virusesинтратекальный синтез иммуноглобулиновMRZ-реакциянейросифилиссифилисантительный индексцереброспинальная жидкостьнейротропные вирусы[Макшаков Г.С., Лапин С.В., Евдошенко Е.П. Современные представления об интратекальном гуморальном иммунном ответе и диагностическое значение выявления олигоклональных иммуноглобулинов при рассеянном склерозе // Журнал неврологии и психиатрии им. С.С. Корсакова. 2016. № 116 (2). С. 14–20. [Makshakov G.S., Lapin S.V., Evdoshenko E.P. Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = The Korsakov’s Journal of Neurology and Psychiatry, 2016, no. 116 (2), pp. 14–20. (In Russ.)] doi: 10.17116/jnevro20161162214-20][Мошникова А.Н., Максимчук В.К., Лапин С.В., Назаров В.Д., Суркова Е.А., Новиков С.А., Макшаков Г.С., Крутецкая И.Ю., Краснов В.С., Кушнир Я.Б., Неофидов Н.А., Тотолян Н.А., Скоромец А.А., Евдошенко Е.П., Тотолян Арег А. Диагностическая значимость интратекального синтеза иммуноглобулинов против нейротропных вирусов (MRZ-реакция) в диагностике рассеянного склероза // Инфекция и иммунитет. 2019. Т. 9, № 5–6. С. 703–712. [Moshnikova A.N., Maksimchuk V.K., Lapin S.V., Nazarov V.D., Surkova E.A., Novikov S.A., Makshakov G.S., Krutetskaya I.Yu.,Krasnov V.S., Kushnir Ya.B., Neofidov N.A., Totolian N.A., Skoromets A.A., Evdoshenko E.P., Totolian Areg A. Diagnostic significance of intrathecally synthesized immunoglobulins against neurotropic viruses (MRZ-reaction) in diagnosis of multiple sclerosis. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2019, vol. 9, no. 5–6, pp. 703–712. (In Russ.)] doi: 10.15789/2220-7619-2019-5-6-703-712][Нейросифилис. Современные представления о диагностике и лечении: руководство для врачей / Под ред. А.В. Самцовa. СПб.: СпецЛит. 2006. 127 с. [Neurosyphilis. Modern views on diagnosis and treatment: a guide for physicians. Ed. Samtsov A.V. St. Petersburg: SpetsLit, 2006. 127 p. (In Russ.)]][Родиков М.В., Прохоренков В.И. Нейросифилис: от диагноза к лечению Часть I. Эпидемиология, патогенез, клиника // Вестник дерматологии и венерологии. 2010. Т. 86, № 1. C. 28–34. [Rodikov M.V., Prokhorenkov V.I. Neurosyphilis: from the diagnosis to treatment. Part I. The epidemiology, pathology and clinic. Vestnik dermatologii i venerologii = Vestnik Dermatologii i Venerologii, 2010, vol. 86, no. 1, pp. 28–34. (In Russ.)] doi: 10.25208/vdv808][Родиков М.В., Прохоренков В.И. Нейросифилис: от диагноза к лечению Часть I.I. Диагностика, терапия, прогноз // Вестник дерматологии и венерологии. 2010. Т. 86, № 2. C. 20–25. [Rodikov M.V., Prokhorenkov V.I. Neurosyphilis: from the diagnosis to treatment Part I.I. Diagnostics, therapy and prognosis. Vestnik dermatologii i venerologii = Vestnik Dermatologii i Venerologii, 2010, vol. 86, no. 2, pp. 20–25. (In Russ.)] 10.25208/vdv892][Российское общество дерматовенерологов и косметологов. Ведение больных инфекциями, передаваемыми половым путем, и урогенительными инфекциями: клинические рекомендации. М.: Деловой Экспресс, 2012. C. 34–68. [Russian Society of Dermatovenerologists and Cosmetologists. Management of patients with sexually transmitted infections and urogenital infections: clinical guidelines. Moscow: Delovoi Ekspress, 2012, pp. 34–68. (In Russ.)]][Соколовский Е., Фриго Н., Ротанов С., Савичева А., Доля О., Китаева Н., Халлен А., Унемо М., Домейка М., Баллард Р. Руководство по лабораторной диагностике сифилиса в странах восточной Европы // Вестник дерматологии и венерологии. 2008. № 5. С. 87–96. [Sokolovskiy E., Frigo N., Rotanov S., Savicheva A., Dolya O., Kitajeva N., Hallen A., Unemo M., Domeika M., Ballard R. Guidelines for the laboratory diagnosis of syphilis in East-European countries. Vestnik dermatologii i venerologii = Vestnik Dermatologii i Venerologii, 2008, no. 5, pp. 87–96. (In Russ.)]][Фриго Н.В., Катунин Г.Л., Ротанов С.В., Левин О.С. Современные иммунологические методы исследования цереброспинальной жидкости у больных нейросифилисом // Вестник дерматологии и венерологии. 2011. № 6. С. 49–57. [Frigo N.V., Katunin G.L., Rotanov S.V., Levin O.S. Up-to-date immunology methods for examination of the cerebrospinal fluid in patients suffering from neurosyphilis. Vestnik dermatologii i venerologii = Vestnik Dermatologii i Venerologii, 2011, no. 6, pp. 49–57. (In Russ.)]][Хронические нейроинфекции / Под ред. И.А. Завалишина, Н.Н Спирина, А.Н. Бойко, С.С. Никитина. М.: ГЭОТАР-Медиа, 2011. 560 с. [Chronic neuroinfections. Eds. I.A. Zavalishina, N.N Spirina, A.N. Bojko, S.S. Nikitina. Moscow: GEOTAR-Media, 2011. 560 p. (In Russ.)]][Aloisi F., Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol., 2006, vol. 6, no. 3, pp. 205–217. doi: 10.1038/nri1786][Bonnan M. Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs? Front. Neurol., 2014, vol. 5: 27. doi: 10.3389/fneur.2014.00027][Caudie C., Garel F., Bancel J., Lombard C., Vandenberghe N. [Diagnosis and biological monitoring of 6 neurosyphilis cases: value of cerebrospinal fluid analysis]. Ann. Biol. Clin. (Paris), 2003, vol. 61, no. 5, pp. 563–569. (In French)][Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., Gambini C., Mancardi G.L., Uccelli A., Pistoia V. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl Acad. Sci. USA, 2004, vol. 101, no. 30, pp. 11064–11069. doi: 10.1073/pnas.0402455101][Felgenhauer K., Schädlich H.J., Nekic M., Ackermann R. Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis? J. Neurol. Sci., 1985, vol. 71, no. 2–3, pp. 291–299. doi: 10.1016/0022-510x(85)90067-x][Jacobi C., Lange P., Reiber H. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response. J. Neuroimmunol., 2007, vol. 187, no. 1–2, pp. 139–146. doi: 10.1016/j.jneuroim.2007.04.002][Jarius S., Eichhorn P., Franciotta D., Petereit H.F., Akman-Demir G., Wick M., Wildemann B. The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature. J. Neurol., 2017, vol. 264, no. 3, pp. 453–466. doi: 10.1007/s00415-016-8360-4][Meinl E., Krumbholz M., Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann. Neurol., 2006, vol. 59, no. 6, pp. 880–892. doi: 10.1002/ana.20890][Otto C., Hofmann J., Finke C., Zimmermann M., Ruprecht K. The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis. Fluids Barriers CNS, 2014, vol. 11, no. 1: 3. doi: 10.1186/2045-8118-11-3][Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J. Neurol. Sci., 2001, vol. 184, no. 2, pp. 101–22. doi: 10.1016/s0022-510x(00)00501-3][Reiber H., Thompson E.J., Grimsley G., Bernardi G., Adam P., Monteiro de Almeida S., Fredman P., Keir G., Lammers M., Liblau R., Menna-Barreto M., Sá M.J., Seres E., Sindic C.J., Teelken A., Trendelenburg C., Trojano M., van Antwerpen M.P., Verbeek M.M. Quality assurance for cerebrospinal fluid protein analysis: international consensus by an Internet-based group discussion. Clin. Chem. Lab. Med., 2003, vol. 41, no. 3, pp. 331–337. doi: 10.1515/CCLM.2003.053][Reiber H., Ungefehr S., Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult. Scler., 1998, vol. 4, no. 3, pp. 111–117. doi: 10.1177/135245859800400304][Sindic C.J., Monteyne P., Laterre E.C. The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J. Neuroimmunol., 1994, vol. 54, no. 1–2, pp. 75–80. doi: 10.1016/0165-5728(94)90233-x][Wurster U., Stachan R., Windhagen A., Petereit H.F., Markus Leweke F. Reference values for standard cerebrospinal fluid examinations in multiple sclerosis. Results from 99 healthy volunteers. Multiple Sclerosis, 2006, pp. S62–S62.]